Tyler Halladay

机构：UCLA Health, Institute of Molecular Medicine

发表论文 9 篇 · 总被引 298 次 · h-index 6

代表论文

• In vivo CAR engineering for immunotherapy (2025 · Nature reviews. Immunology · 被引 111)
• Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies (2024 · Journal of Biomedical Science · 被引 73)
• Breaking the mold: Unconventional T cells in cancer therapy (2024 · Cancer Cell · 被引 39)
• Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture (2025 · Nature Protocols · 被引 28)
• Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety (2025 · Molecular Therapy · 被引 18)
• Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells (2025 · Cell Reports Medicine · 被引 15)